Search Results - de Cabo, Helena Bote

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Targeted therapy for lung cancer: Beyond EGFR and ALK

    Targeted therapy for lung cancer: Beyond EGFR and ALK by Herrera‐Juárez, Mercedes, Serrano‐Gómez, Cristina, Bote‐de‐Cabo, Helena, Paz‐Ares, Luis

    Published in Cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer

    Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer by Siringo, Marco, Baena, Javier, Bote de Cabo, Helena, Torres-Jiménez, Javier, Zurera, María, Zugazagoitia, Jon, Paz-Ares, Luis

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma

    A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma by Hernandez, Susana, Conde, Esther, Alonso, Marta, Illarramendi, Adrian, Bote de Cabo, Helena, Zugazagoitia, Jon, Paz-Ares, Luis, Lopez-Rios, Fernando

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments

    Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments by Torres-Jiménez, Javier, Espinar, Javier Baena, de Cabo, Helena Bote, Berjaga, María Zurera, Esteban-Villarrubia, Jorge, Fraile, Jon Zugazagoitia, Paz-Ares, Luis

    Published in Drugs (New York, N.Y.)
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments

    Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments by Torres-Jiménez, Javier, Espinar, Javier Baena, de Cabo, Helena Bote, Berjaga, María Zurera, Esteban-Villarrubia, Jorge, Fraile, Jon Zugazagoitia, Paz-Ares, Luis

    Published in Drugs (New York, N.Y.)
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    Abstract PO-020: Impact of CDK 4/6i withdrawal or dose adjustment on COVID-19 incidence in HR+/HER2- mBC patients during the pandemic

    Abstract PO-020: Impact of CDK 4/6i withdrawal or dose adjustment on COVID-19 incidence in HR+/HER2- mBC patients during the pandemic by Tolosa, Pablo, Sanchez-Torre, Ana, de Cabo, Helena Bote, Sánchez-Bayona, Rodrigo, Herrera, Mercedes, Yarza, Ramón, Lema, Laura, Manso, Luis, Ciruelos, Eva

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Targeting KRAS G12C in Non-Small-Cell Lung Cancer: Current Standards and Developments

    Targeting KRAS G12C in Non-Small-Cell Lung Cancer: Current Standards and Developments by Torres-Jiménez, Javier, Espinar, Javier Baena, de Cabo, Helena Bote, Berjaga, María Zurera, Esteban-Villarrubia, Jorge, Fraile, Jon Zugazagoitia, Paz-Ares, Luis

    Published in Drugs (New York, N.Y.)
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: